US Tetanus Cases Drop to Historic Lows Over 15-Year Surveillance Period, CDC Reports
Health

US Tetanus Cases Drop to Historic Lows Over 15-Year Surveillance Period, CDC Reports

2026-04-14T20:30:17Z

Tetanus cases in the United States have fallen to historically low levels over a 15-year period from 2009 to 2023, according to new surveillance data released by the Centers for Disease Control and Prevention. The findings highlight the continued effectiveness of widespread vaccination programs in controlling the potentially deadly bacterial infection.

Tetanus, caused by the toxin-producing bacterium Clostridium tetani, can lead to severe muscle stiffness, spasms, and in serious cases, death. The disease is preventable through routine immunization with the tetanus toxoid vaccine, which is administered as part of combination vaccines such as DTaP for children and Tdap or Td boosters for adults.

The surveillance report tracked reported tetanus cases, hospitalizations, and fatalities across all 50 states and the District of Columbia over the study period. Data showed a consistent decline in overall case counts, reinforcing the protective impact of sustained vaccination coverage among both pediatric and adult populations.

Despite the progress, health officials noted that certain demographic groups remain at elevated risk, including adults over the age of 65, unvaccinated individuals, and those who have not received recommended booster doses. Wounds from punctures, cuts, or burns that are not properly treated continue to serve as common entry points for the bacterial spores.

The CDC emphasized the importance of maintaining up-to-date vaccinations and seeking prompt wound care following injuries. Adults are advised to receive a Td or Tdap booster every 10 years to ensure continued protection against tetanus, diphtheria, and pertussis.

Public health officials are urging healthcare providers to review immunization records during routine visits and proactively address vaccination gaps, particularly among older adults and underserved communities where booster uptake may be lower.